IGY Life Sciences announces the closing of $12.8 million (CDN) in new funding to meet high product demand
Press Release | March 24, 2023 Thunder Bay, Ontario, Canada - July 25, 2022 – IGY Life Sciences and Immune Technologies Inc.(the "Company" or "IGY Life Sciences") is pleased to announce the closing of $12.8 million (CDN) in financing this week. This represents the largest single injection of funds into the Company since it [...]